2Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association professional education committee of the council for high blood pressure research[J]. Hypertension, 2008,53.(6) :1403-1419.
3Sire J J, Bhandari SK, Shi J, et al. Characteristics of resistant hy- pertension in a large, ethnically diverse hypertension population of an integrated health system[J]. Mayo Clin Proc, 2013,88 (10) : 1099-1107.
4de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring[J]. Hypertension, 2011,57 (5) :898-902.
5Roberie DR, Elliott WJ. What is the prevalence of resistant hy- pertension in the United States? [J]. Curr Opin Cardiol, 2012,27 (4) :386-391.
6Egan BM, Zhao Y, Li J, et al. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hyperten-sion based on office blood pressure in a community-based practice network[J]. Hypertension, 2013,62 (4) : 691-697.
7Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis[J]. J Hy- pertens,2013,31(4) :766-774.
8Grigoryan L, Pavlik VN, Hyman DJ. Patterns of nonadherence to antihypertensive therapy in primary care [J]. J Clin Hypertens, 2013,15(2) : 107-111.
9Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart at- tack trial (ALLHAT)[J]. J Clin Hypertens,2002,4(6):393-404.
10Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care [J]. Hypertension, 2002,39 (5) :982-988.
